CANADA LIFE ASSURANCE Co
InsurancePosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1046192
WINNIPEG, A2
Position in TEVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$17,111,172
-$899,900 QoQ
Shares Held
568,100
-1.6% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $122,833,157 across 19 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
387,231 | $45,774,576 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
35,536 | $21,072,137 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
568,100 | $17,111,172 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
72,581 | $9,561,820 | |
| 5 | VTRS |
Viatris Inc
|
523,383 | $7,070,904 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
288,429 | $6,902,105 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
38,349 | $2,908,771 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
49,007 | $2,533,171 |
All Filings in TEVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,111,172 | 568,100 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,011,072 | 577,093 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,238,089 | 605,846 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $10,096,609 | 602,423 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $10,266,068 | 667,929 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,383,413 | 697,977 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,299,367 | 571,552 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,708,830 | 535,928 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,777,018 | 480,299 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,983,789 | 381,589 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,423,600 | 727,804 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,685,378 | 356,624 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,446,496 | 502,429 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,540,775 | 497,892 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,498,732 | 433,548 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $3,438,708 | 457,275 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,948,804 | 420,533 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,239,235 | 404,399 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,311,921 | 340,033 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,119,044 | 315,055 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,695,500 | 320,234 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,925,165 | 303,126 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,470,203 | 496,138 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $5,085,015 | 412,410 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $4,052,189 | 451,246 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||